ScholarWorks@Korea University College of Medicine

Browsing by Yoon, Seung KewAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 17 of 17

SCIESCOPUS
A phase IIIb study of ledipasvir/sofosbuvir fixed-dose combination tablet in treatment-na < ve and treatment-experienced Korean patients chronically infected with genotype 1 hepatitis C virus

Lim, Young-Suk, Ahn, Sang Hoon, Lee, Kwan Sik, Paik, Seung Woon, Lee, Youn-Jae, Jeong, Sook-Hyang, Kim, Ju-Hyun, Yoon, Seung Kew, Yim, Hyung Joon, Tak, Won Young, et al.

ArticleIssue Date2016CitationHepatology International, v.10, no.6, pp.947 - 955PublisherSpringer Pub. Co.
SCIESCOPUS
A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma

Woo, Hyun Young, Bae, Si Hyun, Park, Jun Yong, Han, Kwang Hyub, Chun, Ho Jong, Choi, Byung Gil, Im, Hyeon U., Choi, Jong Young, Yoon, Seung Kew, Cheong, Jae Youn, et al.

ArticleIssue Date2010CitationCANCER CHEMOTHERAPY AND PHARMACOLOGY, v.65, no.2, pp.373 - 382PublisherSPRINGER
SCIESCOPUS
A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma

Song, Myeong Jun, Bae, Si Hyun, Chun, Ho Jong, Choi, Jong Young, Yoon, Seung Kew, Park, Jun Young, Han, Kwang Hyub, Kim, Young Seok, Yim, Hyung Joon, Um, Soon Ho, et al.

ArticleIssue Date2015CitationCANCER CHEMOTHERAPY AND PHARMACOLOGY, v.75, no.4, pp.739 - 746PublisherSPRINGER
Adefovir depivoxil for decompensated liver cirrhosis patients with lamivudine- resistant hepatitis B: Multi-center long-term results

Woo, Hyun Young, Choi, Jong Young, Yoon, Seung Kew, Suh, Dong Jin, Paik, Seung Woon, Han, Kwang Hyub, Um, Soon Ho, Kim, Byung Ik, Lee, Heon Ju, Cho, Mong, et al.

ConferenceIssue Date2007Citation58th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, pp.182APublisherJOHN WILEY & SONS INCPlaceUS; Boston, MA
SCIESCOPUS
Antiviral Activity and Safety of LB80380 in Hepatitis B e Antigen-Positive Chronic Hepatitis B Patients with Lamivudine-Resistant Disease

Yuen, Man-Fung, Han, Kwang-Hyub, Um, Soon-Ho, Yoon, Seung Kew, Kim, Hye-Ryon, Kim, John, Kim, Chung Ryeol, Lai, Ching-Lung

ArticleIssue Date2010CitationHEPATOLOGY, v.51, no.3, pp.767 - 776PublisherWILEY
SCOPUSKCI
Assessment of the efficacy of reducing peginterferon alfa-2a and ribavirin dose on virologic response in Koreans with chronic hepatitis C

Kwon, Jung Hyun, Bae, Si Hyun, Choi, Jong Young, Yoon, Seung Kew, Byun, Kwan Soo, Paik, Seung Woon, Lim, Young Suk, Lee, Han Chu, Han, Kwang Hyub, Lee, Kwan Sik

ArticleIssue Date2009CitationThe Korean Journal of Internal Medicine, v.24, no.3, pp.203 - 211Publisher대한내과학회
SCIESCOPUS
Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial

Yim, Hyung Joon, Kim, Won, Ahn, Sang Hoon, Yang, Jin Mo, Jang, Jae Young, Kweon, Yong Oh, Cho, Yong Kyun, Kim, Yoon Jun, Hong, Gun Young, Kim, Dong Joon, et al.

ArticleIssue Date2020CitationAmerican Journal of Gastroenterology, v.115, no.8, pp.1217 - 1225PublisherNLM (Medline)
Comparison of efficacy of hepatic arterial infusion chemotherapy and sorafenib in advanced hepatocellular carcinoma with portal vein tumor thrombosis

Song, Do Seon, Song, Myeong Jun, Lee, Sung Won, Bae, Si Hyun, Chung, Woo Jin, Jang, Jae Young, Kim, Young Seok, Park, Jun Yong, Yim, Hyung Joon, Cho, Sung Bum, et al.

ConferenceIssue Date2013Citation64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, pp.1240A - 1241APublisherWILEY-BLACKWELLPlaceUS; Washington, DC
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: 144 weeks results of phase 3 trialGo to Link

Yim, Hyung Joon, Ahn, Sang Hoon, Kim, Won, Yang, Jin Mo, Jang, Jae Young, Kweon, Young Oh, Cho, Yong Kyun, Kim, Yoon Jun, Hong, Gun Young, Kim, Dong Joon, et al.

ConferenceIssue Date2019CitationInternational Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), pp.E489PublisherELSEVIERPlaceNE; Vienna, AUSTRIA
SCIESCOPUSKCI
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial

Song, Do Seon, Kim, Won, Ahn, Sang Hoon, Yim, Hyung Joon, Jang, Jae Young, Kweon, Young Oh, Cho, Yong Kyun, Kim, Yoon Jun, Hong, Gun Young, Kim, Dong Joon, et al.

ArticleIssue Date2021CitationClinical and Molecular Hepatology, v.27, no.2, pp.346 - 359Publisher대한간학회
SCIESCOPUS
Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus Infectionopen access

Ahn, Sang Hoon, Kim, Won, Jung, Young Kul, Yang, Jin Mo, Jang, Jae Young, Kweon, Yong Oh, Cho, Yong Kyun, Kim, Yoon Jun, Hong, Gun Young, Kim, Dong Joon, et al.

ArticleIssue Date2019CitationCLINICAL GASTROENTEROLOGY AND HEPATOLOGY, v.17, no.9, pp.1850 - +PublisherELSEVIER SCIENCE INC
SCOPUSKCI
High effectiveness of peginterferon alfa-2a plus ribavirin therapy in Korean patients with chronic hepatitis C in clinical practice.

Heo, Nae-Yun, Lim, Young-Suk, Lee, Han Chu, Lee, Yung Sang, Kim, Kang Mo, Byun, Kwan Soo, Han, Kwang-Hyub, Lee, Kwan Sik, Paik, Seung Woon, Yoon, Seung Kew, et al.

ArticleIssue Date2013CitationClinical and Molecular Hepatology, v.19, no.1, pp.60 - 69Publisher대한간학회
SCIESCOPUS
Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis Bopen access

Lai, Ching-Lung, Ahn, Sang Hoon, Lee, Kwan Sik, Um, Soon Ho, Cho, Mong, Yoon, Seung Kew, Lee, Jin-Woo, Park, Neung Hwa, Kweon, Young-Oh, Sohn, Joo Hyun, et al.

ArticleIssue Date2014CitationGUT, v.63, no.6, pp.996 - 1004PublisherBMJ PUBLISHING GROUP
SCIESCOPUSKCI
Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Dataopen access

Kim, Do Young, Kim, Hye Jin, Han, Kwang-Hyub, Han, Sang Young, Heo, Jeong, Woo, Hyun Young, Um, Soon Ho, Kim, Yeul Hong, Kweon, Young Oh, Um, Ho Yeong, et al.

ArticleIssue Date2016CitationCANCER RESEARCH AND TREATMENT, v.48, no.4, pp.1243 - 1252PublisherKOREAN CANCER ASSOCIATION
SCIESCOPUS
Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: Results from a multicentre study

Yuen, Man-Fung, Ahn, Sang Hoon, Lee, Kwan Sik, Um, Soon Ho, Cho, Mong, Yoon, Seung Kew, Lee, Jin-Woo, Park, Neung Hwa, Kweon, Young-Oh, Sohn, Joo Hyun, et al.

ArticleIssue Date2015CitationJOURNAL OF HEPATOLOGY, v.62, no.3, pp.526 - 532PublisherELSEVIER SCIENCE BV
WEEK 48 ANALYSIS OF A PHASE IIB STUDY OF THE EFFICACY AND SAFETY OF LB80380 VS. ENTECAVIR IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B

Lai, Ching-Lung, Ahn, Sang Hoon, Lee, Kwan Sik, Um, Soon Ho, Cho, Mong, Yoon, Seung Kew, Lee, Jin-Woo, Park, Neung Hwa, Kweon, Young-Oh, Sohn, Joo Hyun, et al.

ConferenceIssue Date2011Citation62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), pp.1442APublisherWILEY-BLACKWELLPlaceUS; San Francisco, CA
Week 96 Analysis of a Phase IIb Study of the Efficacy and Safety of Besifovir (LB80380) vs. Entecavir in Treatment-naive Patients with Chronic Hepatitis B

Yuen, Man-Fung, Ahn, Sang Hoon, Lee, Kwan Sik, Um, Soon Ho, Cho, Mong, Yoon, Seung Kew, Lee, Jin-Woo, Park, Neung Hwa, Kweon, Young Oh, Sohn, Joo Hyun, et al.

ConferenceIssue Date2013Citation64th Annual Meeting and Postgraduate Course of the American-Association-for-the-Study-of-Liver-Diseases, pp.693A - 694APublisherWILEY-BLACKWELLPlaceUS; Washington, DC
1
STATISTICS
Total View :7,706,680
Today View :420

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841) 82-2-2286-1265

COPYRIGHT 2020 KOREA UNIVERSITY MEDICAL LIBRARY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어